Heteroaromatic phenylimidazole derivatives as PDE10A enzyme inhibitors

This invention is directed to compounds, which are PDE10A enzyme inhibitors. The invention provides a pharmaceutical composition comprising a therapeutically effective amount of a compound of the invention and a pharmaceutically acceptable carrier. The present invention also provides processes for t...

Full description

Saved in:
Bibliographic Details
Main Authors NIELSEN, JACOB, PUSCHL, ASK, MARIGO, MAURO, KEHLER, JAN, KILBURN, JOHN PAUL, LANGGARD, MORTEN
Format Patent
LanguageEnglish
Published 08.09.2016
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:This invention is directed to compounds, which are PDE10A enzyme inhibitors. The invention provides a pharmaceutical composition comprising a therapeutically effective amount of a compound of the invention and a pharmaceutically acceptable carrier. The present invention also provides processes for the preparation of the compounds of formula I. The present invention further provides a method of treating a subject suffering from a neurodegenerative disorder comprising administering to the subject a therapeutically effective amount of a compound of formula I. The present invention also provides a method of treating a subject suffering from a drug addiction comprising administering to the subject a therapeutically effective amount of a compound of formula I. The present invention further provides a method of treating a subject suffering from a psychiatric disorder comprising administering to the subject a therapeutically effective amount of a compound of formula I.
Bibliography:Application Number: AU20100333435